In difficult markets and economically uncertain times, strong brands that consumers trust are more valuable than ever before. Our strategy is succeeding: Sales of Nasivin® grew by 39% to € 46 million in 2008. Sales of Kytta® soared by 75% to € 15 million. Bion®3 also posted strong growth of 24% to € 44 million, as did Femibion®, which grew 32% to € 26 million. Only our Seven Seas® brand saw a
year-on-year decline in sales of 6.1% to € 42 million due to unfavorable exchange rate movements.
The future strategy builds on the success of our strategic brands, with which we already achieve more than 50% of our global sales.
back
